news industry-news 
STAT
APRIL 9, 2024
The numbers are in, and biotech startups recently closed out their best fundraising quarter in two years, signaling that the industry downturn may soon be a thing of the past. That’s big news for an industry that has been icy for the last three years, once the attention the Covid pandemic brought to drug companies began to fade.
STAT
MAY 14, 2024
This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided. The news of the study was first reported by Bloomberg.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 6, 2024
Abrams, a frequent commentator about vaping in the news media, including CBS This Morning, CNN, and The New Yorker, coordinated extensively with Juul on public messaging in 2017 and 2018, according to company emails.
PharmaVoice
JUNE 8, 2023
Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.
STAT
FEBRUARY 15, 2024
The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election.
STAT
JANUARY 8, 2024
It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual.
STAT
OCTOBER 24, 2023
The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one).
Expert insights. Personalized for you.
347 
Let's personalize your content